Tempest Therapeutics (TPST) 8-K Summary

• Filing Date: November 05, 2025.
• Item Reported: Item 2.02 - Results of Operations and Financial Condition.
• Key Event: The Company issued a press release announcing financial results for the quarter ended September 30, 2025, along with other business highlights.
• Investor Action: Investors must review Exhibit 99.1 (the referenced press release) for the actual financial metrics, performance data, and specific business updates.

This Form 8-K serves only to notify the market of the results release; specific figures